CADL Candel Therapeutics: Company Short-Term Debts

Symbol and logo of brand Candel (CADL)

The price evolution of Candel Therapeutics (CADL) on the GURU.Markets platform reflects debt dynamics, which currently stand at 0.00. The business focuses on developing new tumor therapy methods. Within the framework of ESG standards, the firm is modernizing its laboratories to reduce toxic emissions and conserve energy. Additionally, the organization adheres to a basic eco-regime, minimizing paper documentation and strictly controlling the recycling of chemical waste.

CADL candeltx.com Company Short-Term Loans and Borrowings (07/04/2022 - 10/30/2026)

CADL (Candel Therapeutics Inc.): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price Candel|CADL - Consensus Target
- company stock capitalization data:
Market Capitalization Candel Therapeutics, Inc.|CADL - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Candel Therapeutics|CADL - Accounting Value of Company|Market Cap to Net Assets Ratio candeltx.com|CADL - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital Candel Therapeutics|CADL - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Candel|CADL - Company Aggregate Debts|Debt to Book Capitalization Ratio Candel Therapeutics, Inc.|CADL - Company Long-Term Loans and Borrowings|Company Short-Term Debts Candel Therapeutics|Quick Ratio candeltx.com
- earnings and multiples data:
CADL - Net Income
Analysis of all company metrics:CADL - candeltx.com
Manufactured products of Candel Therapeutics

For Candel Therapeutics (CADL), the short-term debt structure reflects financial stability supported by contract manufacturing organizations in the US. This indicator aggregates all obligations with a maturity of up to one year, including bank loans and accounts payable. Analyzing this trend allows for an assessment of liquidity and the risk of cash flow gaps. The reduction in debt load confirms the autonomy of the research laboratories in Massachusetts, ensuring the uninterrupted conduct of clinical drug trials.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|Accuray (ARAY) - Company Short-Term Debt|SELLAS Life Sciences Group - Company Short-Term Loans and Borrowings|ACTU (Actuate Therapeutics, Inc) - Company Short-Term Debts|Short-Term Debt Citius Oncology Inc CTOR|Company Short-Term Debts HURA|Company Current Liabilities protaratx.com TARA|Company Short-Term Debts FATE (Fate Therapeutics)|Company Short-Term Debts Aadi Bioscience, Inc. WHWK|TCRX - Company Short-Term Debt|CSBR (Champions Oncology) - Company Short-Term Indebtedness|XBIT: Company Short-Term Debts|Company Short-Term Indebtedness CVM|OSTX (OS Therapies) - Company Short-Term Debts|Short-Term Debt Radiopharm Theranostics Ltd RADX|Company Short-Term Debt Artiva Biotherapeutics, Inc. (ARTV)|Company Short-Term Debt ANL (adlainortye.com)|Veru Inc. - Company Current Liabilities|Company Short-Term Loans and Borrowings TPST|XLO: Company Current Liabilities|Renovaro Inc. - Amount of Current Liabilities|MURA: Company Short-Term Debts|Kairos Pharma - Company Short-Term Loans and Borrowings|OKUR (OnKure Therapeutics, Inc.) - Company Short-Term Debts|Short-Term Debt CytoMed GDTC|Company Short-Term Debt Curis, Inc. (CRIS)|APLM (apollomicsinc.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts THAR (Tharimmune Corp)|Company Short-Term Debts Advanced Biomed Inc. ADVB|GNPX - Company Short-Term Debt|Current Liabilities CLDI|SBFM: Company Short-Term Debts|Short-Term Debt Xenetic Biosciences, Inc. (XBIO)|Company Current Liabilities SLRX|Company Short-Term Debts Kitov Pharma|Company Current Liabilities AONC (American Oncology Network)|Amount of Current Liabilities BGNE|Company Short-Term Debts CKPT (Checkpoint Therapeutics, Inc.)|Short-Term Debt Volume Elevation Oncology Inc. (ELEV)|iCAD Corp - Company Short-Term Debts|Ikena Oncology, Inc. (IKNA) - Company Current Liabilities|Notable Labs, Ltd. (NTBL) - Company Short-Term Debt|VIRX - Short-Term Debt Volume|MOR (MorphoSys) - Company Short-Term Debts|Company Current Liabilities NAYA Biosciences Inc (NAYA)|Company Short-Term Debts AAPGV